GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Net Current Asset Value

INFU (InfuSystems Holdings) Net Current Asset Value : $-0.66 (As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

InfuSystems Holdings's net current asset value per share for the quarter that ended in Mar. 2025 was $-0.66.

The historical rank and industry rank for InfuSystems Holdings's Net Current Asset Value or its related term are showing as below:

INFU's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.94
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

InfuSystems Holdings Net Current Asset Value Historical Data

The historical data trend for InfuSystems Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Net Current Asset Value Chart

InfuSystems Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.30 -1.32 -1.28 -0.94 -0.65

InfuSystems Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.94 -1.04 -0.76 -0.65 -0.66

Competitive Comparison of InfuSystems Holdings's Net Current Asset Value

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Price-to-Net-Current-Asset-Value falls into.


;
;

InfuSystems Holdings Net Current Asset Value Calculation

InfuSystems Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net Current Asset Value Per Share(A: Dec. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(32.165-46.085-0-0)/21.272
=-0.65

InfuSystems Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Mar. 2025 is calculated as

Net Current Asset Value Per Share(Q: Mar. 2025 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(35.322-49.134-0-0)/20.974
=-0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InfuSystems Holdings  (AMEX:INFU) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


InfuSystems Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
Executives
Carrie Lachance officer: Executive VP and COO 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele officer: Executive VP and CFO 500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Richard Dilorio officer: Executive Vice President 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr director
Addam Chupa officer: Executive VP and CIO 3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Jerod Funke officer: EVP-Chief HR Officer 3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
Paul Andrew Gendron director 740 BANDIT TRAIL, KELLER TX 76248
R. Rimmy Malhotra director C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman director 309 HADDON COURT, FRANKLIN X1 37067
Christopher R. Sansone director C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Kevin Whitman officer: VP and Corporate Controller 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz officer: VP of Sales and Marketing 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Jeannine Sheehan officer: Chief Administrative Officer 31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p. director 3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp 10 percent owner 405 WEED STREET, NEW CANAAN CT 06840